Is there a need to revise the ESC Guidelines for myocardial revascularisation and chronic coronary syndromes because of the ISCHEMIA trial?

ESC Premium Access

Is there a need to revise the ESC Guidelines for myocardial revascularisation and chronic coronary syndromes because of the ISCHEMIA trial?

Session: Rethinking therapeutic and diagnostic strategies for chronic coronary syndromes: European and Japanese perspectives after the ISCHEMIA trial

Topic: Clinical

Speaker: Doctor B. Gersh (Rochester, US)

Event: ESC Congress 2021 - The Digital Experience

Congress Presentation

About the speaker

Doctor Bernard Gersh

Mayo Clinic, Rochester (United States of America)

8 presentations

0 follower

4 more presentations in this session

Beyond the ISCHEMIA paradigm: updating the role of stress tests, coronary CT and optimisation of medical therapy.

Speaker: Assistant Professor S. Kohsaka (Tokyo, JP)

Access

Slides

Video

How should we manage chronic coronary syndromes after the ISCHEMIA trial?

Speaker: Doctor F. Otsuka (Suita, JP)

Access

Slides

Video

Rethinking therapeutic and diagnostic strategies for chronic coronary syndromes: European and Japanese perspectives after the ISCHEMIA trial – discussion.

Access

Rethinking therapeutic and diagnostic strategies for chronic coronary syndromes: European and Japanese perspectives after the ISCHEMIA trial - Chat Moderator.

Access

Access the full session

Rethinking therapeutic and diagnostic strategies for chronic coronary syndromes: European and Japanese perspectives after the ISCHEMIA trial

Speakers: Doctor B. Gersh, Assistant Professor S. Kohsaka, Doctor F. Otsuka

Access

Video

About the event

ESC Congress 2021 - The Digital Experience

27 August - 30 August 2021

Sessions Presentations

Congress

Is there a need to revise the ESC Guidelines for myocardial revascularisation and chronic coronary syndromes because of the ISCHEMIA trial?

About the speaker

Doctor Bernard Gersh

4 more presentations in this session

Beyond the ISCHEMIA paradigm: updating the role of stress tests, coronary CT and optimisation of medical therapy.

How should we manage chronic coronary syndromes after the ISCHEMIA trial?

Rethinking therapeutic and diagnostic strategies for chronic coronary syndromes: European and Japanese perspectives after the ISCHEMIA trial – discussion.

Rethinking therapeutic and diagnostic strategies for chronic coronary syndromes: European and Japanese perspectives after the ISCHEMIA trial - Chat Moderator.

Access the full session

Rethinking therapeutic and diagnostic strategies for chronic coronary syndromes: European and Japanese perspectives after the ISCHEMIA trial

About the event

ESC Congress 2021 - The Digital Experience

ESC 365 is supported by